EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Patient-reported outcomes with sarecycline treatment for acne vulgaris: Pooled analysis of phase 3 clinical studies

Julie C Harper, April Armstrong, Richard G Fried, Evan A Rieder, Andrew F Alexis, Raidah J Salem, Ismail Kasujee, Ayman Grada

Journal of the American Academy of Dermatology · 2023

DOI: 10.1016/j.jaad.2023.04.075 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Academy of Dermatology, 2023. Verfasst von Julie C Harper und 7 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology and Skin Care Center of Birmingham, Birmingham, Alabama. Hauptthemen laut MEDLINE: Acne Vulgaris, Tetracyclines. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To the Editor: Acne vulgaris is a common chronic inflammatory skin disease that may cause long-term scarring with insufficient treatment.1 Furthermore, the highly visible nature of acne can affect social functioning and health-related quality of life (HRQOL).1 Systemic treatments including antibiotics, such as oral tetracycline-class antibiotics, are generally recommended for patients with moderate-to-severe acne.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acne VulgarisTetracyclinesHumansAnti-Bacterial AgentsPatient Reported Outcome MeasuresQuality of LifeClinical Trials, Phase III as Topic

Stichwörter der Autor:innen

Skindex-16acnedysbiosisemotionfunctioninghealth-related quality of lifenarrow-spectrum antibioticspatient-reported outcomespediatricsarecycline

Substanzen

Anti-Bacterial AgentssarecyclineTetracyclines

Autor:innen und Institutionen

  • Dermatology and Skin Care Center of Birmingham, Birmingham, Alabama.
  • University of Southern California, Los Angeles, California.
  • Yardley Dermatology, Yardley, Pennsylvania.
  • Private Practice, New York, New York.
  • Weill Cornell Medicine, New York, New York.
  • Almirall, LLC, Malvern, Pennsylvania. Electronic address: raidah.salem@almirall.com.

Zitieren

APA

Harper, J. C., Armstrong, A., Fried, R. G., Rieder, E. A., Alexis, A. F., Salem, R. J., Kasujee, I., & Grada, A. (2023). Patient-reported outcomes with sarecycline treatment for acne vulgaris: Pooled analysis of phase 3 clinical studies. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2023.04.075

Vancouver

Harper JC, Armstrong A, Fried RG, Rieder EA, Alexis AF, Salem RJ, et al. Patient-reported outcomes with sarecycline treatment for acne vulgaris: Pooled analysis of phase 3 clinical studies. Journal of the American Academy of Dermatology. 2023. doi:10.1016/j.jaad.2023.04.075

BibTeX
@article{Harper2023,
  author = {Harper, Julie C and Armstrong, April and Fried, Richard G and Rieder, Evan A and Alexis, Andrew F and Salem, Raidah J and Kasujee, Ismail and Grada, Ayman},
  title = {Patient-reported outcomes with sarecycline treatment for acne vulgaris: Pooled analysis of phase 3 clinical studies},
  journal = {Journal of the American Academy of Dermatology},
  year = {2023},
  doi = {10.1016/j.jaad.2023.04.075}
}
Kostenlos starten →